Active Ingredient History
Piracetam is a drug that has efficacy in cognitive disorders, vertigo, cortical myoclonus, dyslexia, and sickle cell anemia; sources differ on its usefulness for dementia. Piracetam is sold as a medication in many European countries. Sale of piracetam is not illegal in the United States, although it is not regulated nor approved by the FDA, so it is legally sold for research use only. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Alzheimer Disease (Phase 4)
Anxiety Disorders (Phase 3)
Cocaine-Related Disorders (Phase 1)
Dementia (Phase 3)
Dementia, Vascular (Phase 4)
Depression (Phase 3)
Postpoliomyelitis Syndrome (Phase 3)
Psychophysiologic Disorders (Phase 3)
Schizophrenia (Phase 3)
Stroke (Phase 4)
Tardive Dyskinesia (Phase 3)
Vertigo (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue